150 related articles for article (PubMed ID: 1623902)
1. In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.
Tani M; Tanimura H; Yamaue H; Iwahashi M; Tsunoda T; Tamai M; Noguchi K; Arii K
Eur J Clin Pharmacol; 1992; 42(6):623-7. PubMed ID: 1623902
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of lymphokine-activated killer cell activity by lentinan.
Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
[TBL] [Abstract][Full Text] [Related]
3. Acting mechanisms of Lentinan in human--II. Enhancement of non-specific cell-mediated cytotoxicity as an interferon inducer.
Miyakoshi H; Aoki T; Mizukoshi M
Int J Immunopharmacol; 1984; 6(4):373-9. PubMed ID: 6207124
[TBL] [Abstract][Full Text] [Related]
4. Effects of lentinan on cytotoxic functions of human lymphocytes.
Péter G; Károly V; Imre B; János F; Kaneko Y
Immunopharmacol Immunotoxicol; 1988; 10(2):157-63. PubMed ID: 3171104
[TBL] [Abstract][Full Text] [Related]
5. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells.
Ladányi A; Tímár J; Lapis K
Cancer Immunol Immunother; 1993; 36(2):123-6. PubMed ID: 8425209
[TBL] [Abstract][Full Text] [Related]
6. [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients].
Amino M; Noguchi R; Yata J; Matsumura J; Hirayama R; Abe O; Enomoto K; Asato Y
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2000-6. PubMed ID: 6225393
[TBL] [Abstract][Full Text] [Related]
7. Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases.
Yamasaki K; Sone S; Yamashita T; Ogura T
Cancer Immunol Immunother; 1989; 29(2):87-92. PubMed ID: 2785852
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan.
Herlyn D; Kaneko Y; Powe J; Aoki T; Koprowski H
Jpn J Cancer Res; 1985 Jan; 76(1):37-42. PubMed ID: 3918909
[TBL] [Abstract][Full Text] [Related]
9. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma.
Arinaga S; Karimine N; Takamuku K; Nanbara S; Inoue H; Nagamatsu M; Ueo H; Akiyoshi T
Int J Immunopharmacol; 1992 May; 14(4):535-9. PubMed ID: 1521921
[TBL] [Abstract][Full Text] [Related]
10. Effect of enkephalins and endorphins on cytotoxic activity of natural killer cells and macrophages/monocytes in mice.
Kowalski J
Eur J Pharmacol; 1997 May; 326(2-3):251-5. PubMed ID: 9196278
[TBL] [Abstract][Full Text] [Related]
11. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass.
Hamano K; Gohra H; Katoh T; Fujimura Y; Zempo N; Esato K
Int J Immunopharmacol; 1999 Aug; 21(8):531-40. PubMed ID: 10458542
[TBL] [Abstract][Full Text] [Related]
12. [Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro].
Li JF; Guo JW; Huang XF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Apr; 16(4):224-6. PubMed ID: 9206247
[TBL] [Abstract][Full Text] [Related]
13. Enhancing effects of new biological response modifier beta-1,3 glucan sulfate PS3 on immune reactions.
Vetvicka V; Vetvickova J; Frank J; Yvin JC
Biomed Pharmacother; 2008 Jun; 62(5):283-8. PubMed ID: 17604941
[TBL] [Abstract][Full Text] [Related]
14. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
15. Immunoprotective effect of lentinan in combination with miltefosine on Leishmania-infected J-774A.1 macrophages.
Shivahare R; Ali W; Singh US; Natu SM; Khattri S; Puri SK; Gupta S
Parasite Immunol; 2016 Oct; 38(10):618-27. PubMed ID: 27387601
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of antitumor effect of recombinant interleukin-2 activated killer cells by the administration of rIL-2 and lentinan.
Shimizu H; Inoue M; Shimizu C; Saito J; Ueda G; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1899-900. PubMed ID: 3264845
[No Abstract] [Full Text] [Related]
17. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
19. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood.
Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ
Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Tsurumoto S
Anticancer Res; 1995; 15(5B):2291-6. PubMed ID: 8572640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
